Mineralocorticoid Receptor Antagonist Use Among Patients With Chronic Kidney Disease Who Transitioned to Dialysis

Mineralocorticoid Receptor Antagonist Use Among Patients With Chronic Kidney Disease Who Transitioned to Dialysis

Saved in:

Bibliographic Details
Main Authors:	Eric M. Tong, MD, Hui Zhou, PhD, Katherine Pak, MS, Cheng-Wei Huang, MD, Benjamin I. Broder, MD, PhD, John J. Sim, MD
Format:	Article
Language:	English
Published:	Elsevier 2025-04-01
Series:	Kidney Medicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2590059525000093
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Aldosterone-Related Cardiovascular Disease and Benefits of Mineralocorticoid Receptor Antagonists in Clinical Practice
by: Maria Alfarano, MD, PhD, et al.
Published: (2025-06-01)

Mineralocorticoid receptor antagonists reduce inflammatory signaling independent of myofiber mineralocorticoid receptor
by: Jeovanna Lowe, et al.
Published: (2025-12-01)

Paradigm shift on the role of mineralocorticoid receptor antagonists in hypertension therapy
by: S. R. Gilyarevsky, et al.
Published: (2023-10-01)

Cardiovascular-Kidney-Metabolic Effects: Steroidal and Nonsteroidal Mineralocorticoid Receptor Antagonists
by: Biykem Bozkurt, et al.
Published: (2025-07-01)

THE USE OF MINERALOCORTICOID RECEPTOR ANTAGONISTS IN THE PRE VENTION OF ATRIAL FIBRILLATION
by: N. T. Vatutin, et al.
Published: (2019-07-01)

A SELECTIVE ANTAGONIST OF MINERALOCORTICOID RECEPTOR EPLERENONE IN CARDIOLOGY PRACTICE
by: B. B. Gegenava, et al.
Published: (2015-09-01)

Investigating the efficacy of mineralocorticoid receptor antagonists for cardiovascular outcomes in different diseases
by: Jiao Wang, et al.
Published: (2025-08-01)

Evidence for the use of a nonsteroidal mineralocorticoid receptor antagonist for the treatment of chronic kidney disease
by: Mariana Morais David Pliças, et al.
Published: (2025-03-01)

Outcomes of Intracoronary Imaging-Guided PCI in Patients With Dialysis
by: Yasushi Ueki, MD, PhD, et al.
Published: (2025-01-01)

Finding of a mass on the mitral valve in a patient on chronic dialysis
by: Vasil Papestiev, MD, PhD, et al.
Published: (2025-04-01)

Adrenal venous sampling outcomes with and without mineralocorticoid receptor antagonists in primary aldosteronism
by: Sittikul Thipbumrung, et al.
Published: (2025-07-01)

Finerenone: a breakthrough mineralocorticoid receptor antagonist for heart failure, diabetes and chronic kidney disease
by: Akshyaya Pradhan, et al.
Published: (2024-12-01)

The use of mineralocorticoid antagonists in chronic heart failure
by: Andrea Szegedi, et al.
Published: (2025-07-01)

Non-Steroidal Mineralocorticoid Receptor Antagonists: A Paradigm Shift in the Management of Diabetic Nephropathy
by: Justine Huart, et al.
Published: (2025-01-01)

Suppression of Rapidly Progressive Mouse Glomerulonephritis with the Non-Steroidal Mineralocorticoid Receptor Antagonist BR-4628.
by: Frank Y Ma, et al.
Published: (2015-01-01)

Re: “Kidney Biopsy-Proven Diabetic and Non-Diabetic Kidney Diseases and Outcomes in Patients With Type 2 Diabetes Receiving Dialysis: The REIN Registry” by Ingwiller et al.
by: Hiroki Ito, MD, PhD
Published: (2025-06-01)

Efficacy and safety of mineralocorticoid receptor antagonists in kidney transplant patients: an updated meta-analysis of randomized controlled trials
by: Paula Dibo, et al.
Published: (2025-08-01)

Recent Advances and Perspectives on the Use of Mineralocorticoid Receptor Antagonists for the Treatment of Hypertension and Chronic Kidney Disease: A Review
by: Kisho Miyasako, et al.
Published: (2024-12-01)

Transitioning spine care from the pediatric to adult center: Challenges and future directions
by: Jesse Shen, MD PhD, et al.
Published: (2025-01-01)

Peritoneal Dialysis-Associated Peritonitis Rates in the Outpatient and Hospital Setting Among Incident Dialysis Patients With Medicare, 2009–2018
by: Christopher Knapp, MD, MPH, et al.
Published: (2025-01-01)

The role of free radical oxidation in the kidneys in the nephroprotective action of eplerenone, a mineralocorticoid receptor antagonist, in experimental diabetes mellitus
by: A. Yu. Zharikov, et al.
Published: (2021-07-01)

A novel transit-time flow metric, diastolic resistance index, detects subcritical anastomotic stenosis in coronary artery bypass graftingCentral MessagePerspective
by: Kenichiro Takahashi, MD, PhD, et al.
Published: (2023-02-01)

Mineralocorticoid Receptor Blocker Prevents Mineralocorticoid Receptor–Mediated Inflammation by Modulating Transcriptional Activity of Mineralocorticoid Receptor–p65–Signal Transducer and Activator of Transcription 3 Complex
by: Naoto Kuyama, et al.
Published: (2024-09-01)

Association Between Mineralocorticoid Receptor Antagonist Use With Worsening Renal Function and Prognosis in Patients With Acute Heart Failure
by: Yudai Fujimoto, et al.
Published: (2025-07-01)

23. Comprehensive Genome Wide Identification and Functional Study of Epithelial Mesenchymal Transition Genes That Regulate Cleft Pathogenesis and Regeneration
by: Eric C. Liao, M.D., Ph.D, et al.
Published: (2025-05-01)

Immune Checkpoint Inhibitors in Kidney Transplant Recipients: A French Multicenter Retrospective Cohort Study
by: Tristan Legris, MD, et al.
Published: (2025-09-01)

A Paired Kidney Analysis of Simultaneous Heart-Kidney Transplantation and Kidney Transplantation After Heart Transplantation
by: Kenji Okumura, MD, et al.
Published: (2025-06-01)

FIDELIO study: significance and place of finerenone as nonsteroidal mineralocorticoid receptor antagonist in therapy of patients with chronic kidney disease in type 2 diabetes
by: M. S. Shamkhalova, et al.
Published: (2023-12-01)

Observation of the therapeutic effect of finerenone, a novel non-steroidal mineralocorticoid receptor antagonist, in patients with non-diabetic CKD
by: Fang Li, et al.
Published: (2025-12-01)

Disparities in Echocardiogram Testing Rates
by: Benjamin S. Wessler, MD, MS, et al.
Published: (2025-08-01)

Preservation of Graft Kidney with De Novo Pelvic Urothelial Carcinoma Via Stereotactic Body Radiation Therapy: A Case Report
by: Koyo Kikuchi, MD, PhD, et al.
Published: (2025-09-01)

Assessment of effectiveness and safety of thrombolytic therapy to pulmonary emboli by endobronchial ultrasound-guided transbronchial needle injectionCentral MessagePerspective
by: Yuki Sata, MD, PhD, et al.
Published: (2023-12-01)

Commentary: Permanent dialysis access following total artificial heart implantation: A question of maturityCentral Message
by: Ashraf Abou El Ela, MD, et al.
Published: (2020-09-01)

Home Dialysis for Undocumented Individuals: A Five-Year Single Center Experience
by: Laurene M. Asare, MD, et al.
Published: (2025-02-01)

How does internal fixation compared with arthroplasty affect quality of life for patients who have suffered femoral neck fractures?
by: Zafar Ahmad, MD, et al.
Published: (2025-06-01)

Post-discontinuation Survival in Patients With Advanced NSCLC Receiving Immune Checkpoint Inhibitors: A Pooled Analysis of Prospective Cohort Studies
by: Yusuke Inoue, MD, PhD, et al.
Published: (2025-08-01)

A Longitudinal Investigation of Chemsex and Its Relationship with Depressive Symptoms Among Gay, Bisexual Men and Other Men Who Have Sex with Men in Taiwan
by: Shih-Chun Hua MS, et al.
Published: (2025-05-01)

Radish Seed Exerts Anti-Diabetic and Obesity-Reducing Effects in Mice by Promoting the Activation of Uncoupling Protein 1 and Peroxisome Proliferator-Activated Receptor-γ Coactivator 1-α
by: Yao-Chien Wang MD, et al.
Published: (2025-02-01)

Transplant of Induced Pluripotent Stem Cell–Derived Retinal Pigment Epithelium Strips for Macular Degeneration and Retinitis Pigmentosa
by: Daiki Sakai, MD, et al.
Published: (2025-07-01)

Targeting Diabetic Atherosclerosis: The Role of GLP-1 Receptor Agonists, SGLT2 Inhibitors, and Nonsteroidal Mineralocorticoid Receptor Antagonists in Vascular Protection and Disease Modulation
by: Merita Rroji, et al.
Published: (2025-03-01)